Karman Stock: 8 Straight Red Days, Down 22%
A persistent slide in the stock has erased a significant amount of market value, leaving a mixed picture when set against its fundamentals.
Shares of Karman (KRMN) have fallen for 8 consecutive trading days, a slide that has erased 22% of the stock’s value. The move cut about $1.8 billion from the company’s market capitalization, which now stands at about $6.4 billion.
This recent drop accounts for nearly the entirety of the stock’s performance over the last three months, a period in which it has returned -23.8%.
The Streak Next To The S&P 500
Here is how KRMN stock stacks up against the S&P 500 over the streak and the periods around it:
| Return Period | KRMN | S&P 500 |
|---|---|---|
| 1D | -1.7% | -0.0% |
| 8D (Current Streak) | -22.0% | -1.4% |
| 1M (21D) | -2.3% | 3.3% |
| 3M (63D) | -23.8% | 2.1% |
| YTD 2026 | -33.9% | 12.1% |
| 2025 | 16.4% | |
| 2024 | 23.3% | |
| 2023 | 24.2% |
What does the data say about this price?
The evidence is mixed. The market’s broader movement over the same 8 trading days, when the S&P 500 returned -1.4%, does not account for the stock’s decline. From a business perspective, Karman’s revenue grew 50.2% over the last twelve months, far outpacing the S&P 500 median of 8.4%.
However, its operating margin of 16.8% sits just below the S&P 500 median of 18.5%. And after this slide, the stock still trades at a price-to-earnings multiple of 172.4, substantially higher than the S&P 500 median of 23.5.
How should an investor treat a streak?
A streak is a piece of information, not an instruction. It tells you that a stock has momentum and has captured the market’s attention, for better or worse. It is not, by itself, a signal to buy or sell. The disciplined response is to do exactly what these numbers allow: check the story of the business against the new reality of its price. A streak simply creates a clear moment to ask if that relationship still makes sense.
Investors typically avoid relying solely on falling prices as a buying trigger. Our Buy the Dip screen ranks the marked-down names where growth and cash generation still support a recovery.
Prefer the theme to this single name? Our ETF Scorecard shows how the aerospace & defense funds stack up. It is still a concentrated bet on that one theme, though, which is exactly the gap the portfolio below closes.
Falling Prices Test Conviction. Rules Do Not Flinch
A losing streak forces a choice on every holder: sell into weakness, average down, or freeze. All three are emotional answers to what should be an analytical question, and emotions priced at market open are expensive.
The Trefis High Quality (HQ) Portfolio takes the emotion out: about 30 quality businesses screened for the fundamentals that survive bad stretches, held and rebalanced by rules. It has a track record of outpacing a benchmark that combines the three major indices – the S&P 500, S&P Mid-cap, and Russell 2000. Let the rules do the heavy lifting for you.